CS logo
small CS logo
University of Missouri - Ellis Fischel

Columbia, Missouri, United States
Health center in Columbia, Missouri
1 Hospital Dr, Columbia, MO 65212

About University of Missouri - Ellis Fischel


Ellis Fischel Cancer Center is a member of University of Missouri Health Care in Columbia, Missouri. It was the first free-standing cancer center west of the Mississippi River and the second such institution of its kind in the United States.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at University of Missouri - Ellis Fischel


During the past decade, University of Missouri - Ellis Fischel conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 129 clinical trials were completed, i.e. on average, 159.3% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 46 clinical trials were completed. i.e. 164.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Missouri - Ellis Fischel" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 118 trials, followed by "National Cancer Institute (NCI)" with 85 trials sponsored, "Radiation Therapy Oncology Group" with 45 trials sponsored, "Gynecologic Oncology Group" with 36 trials sponsored and "SWOG Cancer Research Network" with 36 trials sponsored. Other sponsors include 119 different institutions and companies that sponsored additional 49 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Missouri - Ellis Fischel" #1 collaborator was "National Cancer Institute (NCI)" with 299 trials as a collaborator, "Cancer and Leukemia Group B" with 28 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "SWOG Cancer Research Network" with 23 trials as a collaborator and "Eastern Cooperative Oncology Group" with 19 trials as a collaborator. Other collaborators include 92 different institutions and companies that were collaborators in the rest 47 trials.

Clinical Trials Conditions at University of Missouri - Ellis Fischel


According to Clinical.Site data, the most researched conditions in "University of Missouri - Ellis Fischel" are "Breast Cancer" (34 trials), "Lung Cancer" (32 trials), "Lymphoma" (25 trials), "Leukemia" (24 trials) and "Colorectal Cancer" (18 trials). Many other conditions were trialed in "University of Missouri - Ellis Fischel" in a lesser frequency.

Clinical Trials Intervention Types at University of Missouri - Ellis Fischel


Most popular intervention types in "University of Missouri - Ellis Fischel" are "Drug" (346 trials), "Other" (146 trials), "Biological" (117 trials), "Radiation" (105 trials) and "Procedure" (85 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (78 trials), "radiation therapy" (56 trials), "Quality-of-Life Assessment" (48 trials), "cisplatin" (33 trials) and "Questionnaire Administration" (31 trials). Other intervention names were less common.

Clinical Trials Genders at University of Missouri - Ellis Fischel


The vast majority of trials in "University of Missouri - Ellis Fischel" are 305 trials for "All" genders, 104 trials for "Female" genders and 27 trials for "Male" genders.

Clinical Trials Status at University of Missouri - Ellis Fischel


Currently, there are NaN active trials in "University of Missouri - Ellis Fischel". undefined are not yet recruiting, 36 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 273 completed trials in University of Missouri - Ellis Fischel, 4 suspended trials, and 36 terminated clinical trials to date.
Out of the total trials that were conducted in University of Missouri - Ellis Fischel, 22 "Phase 1" clinical trials were conducted, 173 "Phase 2" clinical trials and 217 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".